-transparent.png){kind=logo}
The retinoic acid derivative Ro 10-9359, given orally in maximum daily doses of 100 mg to 15 patients with psoriasis vulgaris, led to clearing of the lesions in 8 patients. The average period of treatment was 9 weeks. In 14 patients side-effects were observed, the most important being palmo-plantar desquamation, shivering, thirst and diffuse hair loss. In 2 patients scaling led to withdrawal. In 6 patients abnormal alkaline phosphatase and glutamic-aspartatic transaminase values, partly transient, developed (glutamicaspartatic transaminase, p less than 0.01).
Related Publications
B Dahl, and
K Mollenbach, and
F Reymann
February 1980,
The British journal of dermatology,
B Dahl, and
K Mollenbach, and
F Reymann
October 1981,
The New Zealand medical journal,
B Dahl, and
K Mollenbach, and
F Reymann
August 1981,
The New Zealand medical journal,
B Dahl, and
K Mollenbach, and
F Reymann
January 1981,
Dermatologica,
B Dahl, and
K Mollenbach, and
F Reymann
January 1978,
Medicina cutanea ibero-latino-americana,
B Dahl, and
K Mollenbach, and
F Reymann
January 1976,
Dermatologica,
B Dahl, and
K Mollenbach, and
F Reymann
January 1983,
Dermatologica,
B Dahl, and
K Mollenbach, and
F Reymann
January 1978,
Dermatologica,
B Dahl, and
K Mollenbach, and
F Reymann
April 1976,
Zeitschrift fur Hautkrankheiten,
B Dahl, and
K Mollenbach, and
F Reymann
January 1986,
Acta Universitatis Carolinae. Medica,
